The short answer: Some people feel more anxious, restless, or sleepless soon after they start an SSRI. Doctors call this activation or jitteriness/anxiety syndrome. Nobody has proved why it happens, and studies put the rate anywhere from 4% to 65%. It usually eases as treatment continues, but no good study fixes the day it stops, so tell your prescriber early.
What is the early worsening on an SSRI?
It is a group of symptoms that appears after a person starts an antidepressant. The UK guideline body NICE calls it activation. Its guideline on generalised anxiety disorder describes it as "increased anxiety, agitation and problems sleeping" with SSRIs and SNRIs.
Researchers use a second name: jitteriness/anxiety syndrome. A 2009 systematic review in the British Journal of Psychiatry looked at 107 articles on it. The review described early worsening of anxiety, agitation, and irritability. It also found no validated rating scale for the syndrome, and it said the syndrome "remains poorly characterised."
That matters for you as a reader. The feeling is real and prescribers plan for it. But each study counts different symptoms over different time periods, so the numbers do not line up.
How common is it?
Estimates vary widely. The 2009 review found published rates from 4% to 65% of people who start an antidepressant. Three later studies show why the range is so wide:
- 4.3%. A 2008 review of case records followed 729 outpatients for three months. Thirty-one developed activation syndrome.
- 7.0%. A 2014 prospective study followed 301 patients for one month. Twenty-one developed the syndrome.
- 27.7%. A 2017 study of 209 patients used rating scales at two and six weeks. Only 6.7% had the syndrome in the first two weeks. The rate was 27.7% across six weeks.
The study that used rating scales at set visits found the most cases. The method may explain part of the gap. The first two studies also found no link to the class of antidepressant. The 2009 review found no firm evidence that SSRIs cause it more than older tricyclic drugs, or that people with anxiety disorders get it more often.
The 2017 study found one clear risk factor: dose. People on a high dose had about 2.7 times the odds of the syndrome.
Why might an SSRI raise anxiety at first?
The honest answer is that nobody knows for certain. The leading idea is a hypothesis, and most of the evidence comes from animals.
An SSRI raises serotonin quickly. The benefit takes weeks to arrive. One theory says the early serotonin rise acts on a receptor called 5-HT2C in a fear circuit before the brain adapts. A 2016 mouse study in Nature traced such a circuit in a region called the extended amygdala. The authors called it a "potential mechanistic explanation" for early adverse events in some patients. That is a careful phrase, and it describes mice.
Human evidence is thinner. In a small trial of 32 healthy volunteers, one dose of citalopram increased the startle response and the recognition of fearful faces compared with placebo. The authors said this "could underlie" early anxiety on SSRIs. They did not test patients.
So treat the receptor story as a possible explanation. It does not predict who will get the symptoms.
When does it ease?
Most descriptions place it in the first days to weeks of treatment. No study gives a reliable end date. The 2009 review set out to describe the time course and concluded that the syndrome was still poorly defined.
Two facts help set expectations:
- The National Institute of Mental Health says antidepressant side effects "are generally mild and tend to go away with time." The NIMH medication page also says the drugs usually take 4 to 8 weeks to work.
- The symptoms can start later than people expect. In the 2017 study, most cases appeared after the second week. A dose increase is a second time to watch for them.
If the restlessness has not eased after a couple of weeks, or it gets worse, report it. Do not wait for it to pass. For the usual timeline of benefit from each drug class, see how long anxiety medication takes to work.
How do prescribers handle it?
They warn you first. NICE tells prescribers to give written and verbal information about the risk of activation before they prescribe an SSRI or SNRI.
If side effects appear soon after the start, NICE lists three options for the prescriber:
- Monitor the symptoms closely, if they are mild and acceptable to the person.
- Reduce the dose.
- Stop the drug and offer a different drug or a psychological treatment.
A lower start is built into some labels. The FDA label for sertraline (Zoloft) lists a starting dosage of 25 mg per day for panic disorder, PTSD, and social anxiety disorder. It lists 50 mg per day for major depressive disorder. In the label's placebo-controlled studies, agitation led 2% of sertraline patients to stop treatment. Insomnia led another 2% to stop.
The 2009 review found two common strategies: a slower dose increase and a short course of a benzodiazepine. It also said conclusive evidence that either one works is lacking. Trouble sleeping is a frequent part of the picture, and this guide to anxiety and sleep covers the non-drug options.
These are decisions for your prescriber. The sertraline Medication Guide says not to stop the drug without talking to your healthcare provider first, because stopping too quickly can cause serious symptoms.
Which warning signs need a same-day call?
The sertraline label carries a boxed warning. It says antidepressants increased the risk of suicidal thoughts and behaviors in children and young adults in short-term studies. The sertraline label reports pooled trial data per 1,000 patients treated: 14 additional cases under age 18 and 5 additional cases at ages 18 to 24, compared with placebo. At ages 25 to 64 there was 1 fewer case. The same warning applies when the drug treats depression, a topic that depression.md covers.
The label tells prescribers to monitor closely during the first few months and at dose changes. NICE says people under 30 should be seen within 1 week of the first prescription, then checked weekly for the first month.
The sertraline Medication Guide says to call your healthcare provider right away, or call 911 in an emergency, if any of these are new, worse, or worry you:
- Thoughts about suicide or dying, or a suicide attempt
- New or worse anxiety or panic attacks
- Feeling agitated, restless, angry, or irritable
- Trouble sleeping
- Acting aggressive or violent, or acting on dangerous impulses
- An increase in activity or talking more than is normal for you
- New or worse depression
If you have thoughts of suicide, call or text 988 (the 988 Suicide and Crisis Lifeline) now. Call 911 if life is in danger. For other symptoms that need medical care, see when to see a doctor for anxiety.
The bottom line
Early worsening on an SSRI is a known effect with a weak evidence base. Rates in studies run from 4% to 65%, the cause is a hypothesis, and no study gives a firm end date. What is clear is the plan: expect it as a possibility, report it early, and let your prescriber adjust the treatment. Thoughts of self-harm, severe agitation, or new panic attacks need a call the same day.
Last updated: October 2026. This article is for informational purposes only and does not constitute medical advice. Do not start, stop, or change the dose of an antidepressant without talking to your prescriber. If you are in crisis, call or text 988.